ClinicalTrials.gg
Drug

Atogepant clinical trials

Also written Qulipta and AGN-241689.

studies test it
22
open now
6
in phase 3
16
first study started
2016

How each study uses atogepant is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the atogepant studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
28 Sept 2021 · QULIPTA · NDA 215206 (FDA, Drugs@FDA)
European Union
11 Aug 2023 · Aquipta · EMEA/H/C/005871 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Atogepant
16
Atogepant 60 mg
6
Aquipta
4

Brand

Qulipta
11

Development codes

AGN-241689
3

Studies by the year they started

21 studies that test it; most in 2021 (4); 1 more planned to start later

Studies that test atogepant, by start year
YearStudies
20161
20182
20192
20201
20214
20222
20234
20241
20253
20261

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
1
Phase 3
16
Phase 4
4

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 19 · Other 3

AbbVie (12) · Allergan (7) · Konrad Peter Weber (1) · Stanford University (1) · Mayo Clinic (1)

Often tested with

Tested in the same studies.

Ubrogepant (2) · Galcanezumab (1) · Erenumab (1) · Eptinezumab (1) · Propranolol (1) · Topiramate (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses atogepant is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 22

See all 22 studies that test atogepant →

Given beside what is tested · 1 — atogepant is usual care or a partner of the new treatment

Codes

What other systems call atogepant · ClinicalTrials.gg INT001702

  • MeSH (NLM) C000718987atogepantConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 7CRV8RR151ATOGEPANTConfirmed FDA, NLM, Wikidata
  • RxNorm 2571813One source FDA
  • Wikidata Q76797798atogepantConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C167018AtogepantOne source FDA
  • DrugBank DB16098One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.